Market Value3,394,006,000
Total Holdings82
File Date2019-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
US29266S3040 / Endologix, Inc.
LOGC / ContextLogic Holdings Inc.
04269XAB1 / Array Biopharma Inc Bond
MOR / MorphoSys AG - Depositary Receipt (Common Stock)
XERS / Xeris Biopharma Holdings, Inc.
UNH / UnitedHealth Group Incorporated
NVRO / Nevro Corp.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
VAPO / Vapotherm, Inc.
FOLD / Amicus Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
TCDA / Tricida Inc
SGRY / Surgery Partners, Inc.
CBAY / CymaBay Therapeutics, Inc.
ARVN / Arvinas, Inc.
TDOC / Teladoc Health, Inc.
OVID / Ovid Therapeutics Inc.
BOLD / Boundless Bio, Inc.
CI / The Cigna Group
EHTH / eHealth, Inc.
TNDM / Tandem Diabetes Care, Inc.
/ Array BioPharma, Inc.
XNCR / Xencor, Inc.
ADVM / Adverum Biotechnologies, Inc.
GLYC / GlycoMimetics, Inc.
ANAB / AnaptysBio, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
QURE / uniQure N.V.
KRYS / Krystal Biotech, Inc.
/ Oxford Immunotec Global PLC
HSKA / Heska Corp. (Restricted Voting)
DCPH / Deciphera Pharmaceuticals, Inc.
RGNX / REGENXBIO Inc.
ICUI / ICU Medical, Inc.
GOSS / Gossamer Bio, Inc.
ATRC / AtriCure, Inc.
EPZM / Epizyme Inc
CMRX / Chimerix, Inc.
NVTA / Invitae Corporation
ALGN / Align Technology, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
FLXN / Horizon Funds - Horizon Flexible Income ETF
SWAV / Shockwave Medical, Inc.
AVDR / New Age Alpha Trust - AVDR US LargeCap Leading ETF
IFRX / InflaRx N.V.
VKTX / Viking Therapeutics, Inc.
US69354M1080 / PRA Health Sciences Inc
LHCG / LHC Group Inc
ODT / Odonate Therapeutics Inc
IMGN / ImmunoGen, Inc.
CELG / Celgene Corp.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
GBT / Global Blood Therapeutics Inc.
US62857M1053 / MyoKardia, Inc.
AXNX / Axonics, Inc.
SIBN / SI-BONE, Inc.
JNCE / Jounce Therapeutics Inc
SYRS / Syros Pharmaceuticals, Inc.
US014339AA35 / Alder Biopharmaceuticals Inc Bond
JAZZ / Jazz Pharmaceuticals plc
VCEL / Vericel Corporation
CSLT / Castlight Health Inc - Class B
BIIB / Biogen Inc.
BMY / Bristol-Myers Squibb Company
ARGX / argenx SE - Depositary Receipt (Common Stock)
CLVS / Clovis Oncology Inc
WVE / Wave Life Sciences Ltd.
REPL / Replimune Group, Inc.
ATRA / Atara Biotherapeutics, Inc.
98235T107 / Wright Medical Group N.V.
AUPH / Aurinia Pharmaceuticals Inc.
TCRR / Tcr2 Therapeutics Inc
ANTM / Anthem Inc
PEN / Penumbra, Inc.
SRRK / Scholar Rock Holding Corporation
FATE / Fate Therapeutics, Inc.
GWP / GW Pharmaceuticals plc
LIVN / LivaNova PLC
GRTS / Gritstone bio, Inc.
ESTA / Establishment Labs Holdings Inc.
ALLK / Allakos Inc.